Skip to main content
48°
Sunny
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Dexcom Inc
(NQ:
DXCM
)
70.35
-0.13 (-0.18%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Nov 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Dexcom Inc
< Previous
1
2
3
4
5
6
7
8
9
...
23
24
Next >
Why DexCom Stock Flopped on Friday
October 25, 2024
Investors likely felt that with a compelling new product on the market, the company should have posted more meaningful growth.
Via
The Motley Fool
Analyst Expectations For DexCom's Future
October 25, 2024
Via
Benzinga
These Analysts Revise Their Forecasts On DexCom Following Q3 Results
October 25, 2024
Via
Benzinga
Nasdaq Up Triple Digits As Stocks Rally, Yields Cool
October 25, 2024
Stocks are finishing the week strong, but it's a pyrrhic victory, with two of the three major indexes still staring down sizable weekly losses.
Via
Talk Markets
Stock Market Mixed But Nasdaq Hits Record High As Tesla Leads Earnings Winners: Weekly Review
October 25, 2024
The major indexes were mixed for the week.
Via
Investor's Business Daily
Where Will DexCom Be in 5 Years?
October 18, 2024
Recent developments might have scared away some investors, but patience could pay off.
Via
The Motley Fool
Why NASDAQ:DXCM Is a Promising High-Growth Stock in the Midst of Consolidation.
October 16, 2024
Why DEXCOM INC (NASDAQ:DXCM) Is a Standout High-Growth Stock in a Consolidation Phase.
Via
Chartmill
Tech Stocks Rally As Investors Await Magnificent 7 Earnings; Dollar Eyes Fourth Straight Positive Week: What's Driving Markets Friday?
October 25, 2024
Stocks are ending the week on a high note, with tech leading the charge as investors position ahead of next week’s pivotal earnings releases from five of the “Magnificent Seven” stocks.
Via
Benzinga
Capri, Coursera, DexCom And Other Big Stocks Moving Lower In Friday's Pre-Market Session
October 25, 2024
Via
Benzinga
Looking Into DexCom's Recent Short Interest
October 09, 2024
Via
Benzinga
$100 Invested In This Stock 15 Years Ago Would Be Worth $3,600 Today
October 08, 2024
Via
Benzinga
$100 Invested In DexCom 15 Years Ago Would Be Worth This Much Today
September 30, 2024
Via
Benzinga
What the Options Market Tells Us About DexCom
September 26, 2024
Via
Benzinga
DexCom (DXCM) Q3 2024 Earnings Call Transcript
October 24, 2024
DXCM earnings call for the period ending September 30, 2024.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
DexCom Stock Drops After Q3 Results, Announces C-Suite Transition
October 24, 2024
DexCom reported its third-quarter results after Thursday's closing bell. Here's a look at the details from the report.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
October 24, 2024
Via
Benzinga
Dexcom Tops Quarterly Expectations And Keeps Its Guidance. But Shares Crash.
October 24, 2024
The company continues to expect 11% to 13% organic sales growth this year.
Via
Investor's Business Daily
Jim Cramer Calls AST SpaceMobile 'Overvalued,' Warns HubSpot Is 'Playing With Fire'
October 22, 2024
Cheniere Energy (LNG) is a buy, while GE Vernova (GEV) may sell off on good news. HubSpot (HUBS) is risky, NuScale Power (SMR) is losing money, and AST SpaceMobile (ASTS) is overvalued.
Via
Benzinga
Is DexCom a Millionaire Maker?
September 25, 2024
It isn't the most likely candidate to make someone a millionaire, but it's theoretically possible.
Via
The Motley Fool
Tech Stocks Rebound, Tesla Soars To Best Day Since March 2021, Gold Rises As Treasury Yields Ease: What's Driving Markets Thursday?
October 24, 2024
Tech stocks outperformed on Thursday, driven by Tesla Inc. (NASDAQ:TSLA), which skyrocketed 18% in midday trading following stronger-than-expected quarterly financial results.
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
October 16, 2024
Via
Benzinga
2 Magnificent Stocks to Buy That Are Near 52-Week Lows
October 12, 2024
A discounted stock can present an opportunity when there's a quality business behind it.
Via
The Motley Fool
Tech Stocks Rebound With Tesla Soaring To Best Day Since March 2021, Gold Rises As Treasury Yields Ease: What's Driving Markets Thursday?
October 24, 2024
Tech stocks outperformed on Thursday, driven by Tesla Inc. (NASDAQ:TSLA), which skyrocketed 18% in midday trading following stronger-than-expected quarterly financial results.
Via
Benzinga
Down More Than 50% From Its High, Is DexCom Stock a Buy?
October 09, 2024
Is DexCom's business in trouble, or could this be a great buying opportunity for investors?
Via
The Motley Fool
2 Beaten-Down Growth Stocks You Might Regret Not Buying
October 05, 2024
Their headwinds won't last forever.
Via
The Motley Fool
Is DexCom a Millionaire Maker?
October 05, 2024
The company's game-changing technology could improve the lives of hundreds of millions of patients.
Via
The Motley Fool
Eli Lilly Leads S&P Health Care Stocks With 1,241% Gain. But The Others Aren't Slackers.
October 03, 2024
Eli Lilly has gained markedly over the past decade. But it's not the only S&P 500 health care stock to notch a bullish gain.
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
Down More Than 50%, Is DexCom Stock a Bargain Now?
October 02, 2024
Demand for blood glucose monitors is strong, but DexCom isn't the only competitor in this lucrative market.
Via
The Motley Fool
2 Magnificent Growth Stocks Down 45% and 32% to Buy Right Now
September 30, 2024
Sometimes, a discounted stock can present a valuable opportunity.
Via
The Motley Fool
DexCom Is Great. Here's Why You Shouldn't Buy It.
September 25, 2024
Two key uncertainties make the prospect of buying it today riskier than is desirable.
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
...
23
24
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.